Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06101329 |
|---|---|
| Brief Title: | Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) (PURPOSE 3) |
| First Submitted : | October 20, 2023 |
| First Submitted that Met QC Criteria : | October 20, 2023 |
| First Posted : | October 26, 2023 |
| Last Update Submitted that Met QC Criteria : | May 2, 2024 |
| Last Update Posted : | May 3, 2024 |